Bismuth‐Containing Quadruple Therapy as Second‐Line Treatment for <i>Helicobacter pylori</i> Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea

Abstract

Two-week bismuth-containing quadruple therapy was more effective than the 1-week treatment, and should be considered for second-line treatment in Korea.